NIHR-funded researchers are working with communities on three continents to improve the patient journey and reduce stigma for people with cutaneous leishmaniasis.
Cutaneous leishmaniasis is a disfiguring skin disease that affects people in more than 90 countries around the world. NIHR researchers have placed community engagement and involvement at the heart of their research, which is key to developing interventions that benefit and empower people with cutaneous leishmaniasis.